Reata Pharmaceuticals Announcements
Reata Pharmaceuticals (RETA) announced that the abstracts highlighting clinical data for bardoxolone methyl (“bardoxolone”) and disease education data on Alport syndrome will be presented at the American Society of Nephrology Kidney Week 2021 being held virtually from November 4 – 7, 2021.
The abstracts for the oral and poster presentations are listed below and are available on the conference website at https://www.asn-online.org/education/kidneyweek/.
Abstract Title: Integrated Efficacy and Safety of Bardoxolone Methyl in Chronic Kidney Disease
Presenter: Laura Mariani, MD, Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA
Session: OR2102. Findings from Landmark Trials, Other Kidney Trials, and Observational Studies
Abstract Publication: FR-OR54